drugset / Trial / NCT02564861

Multiple Dose Study of D1971a in Healthy Volunteers

NCT02564861

Phase 1 Completed 25 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindBasic science

Summary

This is a randomised, double-blind, placebo-controlled multiple dose study designed to explore the safety, tolerability and PK of DS-1971a following oral administration over 14 days to healthy male and female subjects. Each participant receives lidocaine as a local anaesthetic before inserting the intravenous cannula.

Timeline

Start
2015-09
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DS-1971 Small molecule Oral

Indications

No indication recorded.